BRPI1001959A2 - Nanocarreadores coloidais para ativos hidrofílicos e processo de produção - Google Patents

Nanocarreadores coloidais para ativos hidrofílicos e processo de produção Download PDF

Info

Publication number
BRPI1001959A2
BRPI1001959A2 BRPI1001959-6A BRPI1001959A BRPI1001959A2 BR PI1001959 A2 BRPI1001959 A2 BR PI1001959A2 BR PI1001959 A BRPI1001959 A BR PI1001959A BR PI1001959 A2 BRPI1001959 A2 BR PI1001959A2
Authority
BR
Brazil
Prior art keywords
hydrophilic
assets
phase
production process
colloidal
Prior art date
Application number
BRPI1001959-6A
Other languages
English (en)
Inventor
Neto Pereira Cerize Natália
Marim De Oliveira Adriano
Inês Ré Maria
Claudio Tedesco Antonio
Original Assignee
Instituto De Pesquisas Tecnológicas Do Est. S. Paulo S/a - Ipt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto De Pesquisas Tecnológicas Do Est. S. Paulo S/a - Ipt filed Critical Instituto De Pesquisas Tecnológicas Do Est. S. Paulo S/a - Ipt
Priority to BRPI1001959-6A priority Critical patent/BRPI1001959A2/pt
Priority to US13/704,382 priority patent/US20130197100A1/en
Priority to PCT/BR2011/000185 priority patent/WO2011156880A1/pt
Priority to JP2013514500A priority patent/JP2013530168A/ja
Priority to EP11794970.1A priority patent/EP2583671A4/en
Publication of BRPI1001959A2 publication Critical patent/BRPI1001959A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

NANOCARREADORES COLOIDAIS PARA ATIVOS HIDROFILICOS E PROCESSO DE PRODUÇçO pertence ao setor de preparações para finalidades médicas, odontológicas ou de higiene caracterizado por serem estruturas formadas por polímeros hidrofílicos contendo ativos hidrofílicos, envoltos por uma fase não hidrofílica e tensoativos que possuem atração pelos componentes, formando uma emulsão inversa, que permite a incorporação e veiculação controlada de ativos h idrofílicos, conferindo-lhe propriedades como proteção contra processos de degradação, melhoria da compatibilidade com os outros constituintes da formulação do produto final, aumento da disponibilidade e/ou biodisponibilidade do ativo para o meio de interesse (incluindo melhorias em processos de permeação em materiais biológicos, redução da exposição e volatilização do ativo para o meio) e liberação controlada do(s) ativo(s). O nanocarreador obtido por este processo, denominado de Nanocarreadores Coloidais (NCs), pode ser aplicado em áreas diversas como farmacêutica (incluindo dermatológica), cosmética, produtos de higiene pessoal, veterinária, agroquímica e fertilizantes, alimentos e outros afins. "NANOCARREADORES COLOIDAIS PARA ATIVOS HIDROFILICOS E PROCESSO DE PRODUÇçO" apresenta um sistema cineticamente estável e eficiente quanto à nanoestrutura, que consiste em nanocarreadores formados por polímeros emulsificados em um meio não aquoso, na presença de um tensoativo que possui atração pelas duas fases (meio dispersante e agente encapsulante). Este sistema é obtido por meio da nanoemulsificação de uma fase aquosa de polímeros hidrofílicos, emulsificados em uma fase não hidrofílica (lipofílica ou silofílica) contendo o tensoativo destacando-se pela aplicação de dois conceitos que abrangem a geração de uma nanoemulsão inversa e de nanopartículas poliméricas. A formulação gera o efeito técnico novo de um veículo polimérico nanoestruturado para veiculação de moléculas hidrofílicas suspenso em fase não hidrofílica, passível de controle de tamanho de partícula em escala nanométrica e de modulação da estabilidade coloidal através de parâmetros de processo.
BRPI1001959-6A 2010-06-15 2010-06-15 Nanocarreadores coloidais para ativos hidrofílicos e processo de produção BRPI1001959A2 (pt)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BRPI1001959-6A BRPI1001959A2 (pt) 2010-06-15 2010-06-15 Nanocarreadores coloidais para ativos hidrofílicos e processo de produção
US13/704,382 US20130197100A1 (en) 2010-06-15 2011-06-14 Colloidal nanoscale carriers for active hydrophilic substances and method for producing same
PCT/BR2011/000185 WO2011156880A1 (pt) 2010-06-15 2011-06-14 Nanocarreadores coloidais para ativos hidrofílicos e processo de produção
JP2013514500A JP2013530168A (ja) 2010-06-15 2011-06-14 親水性活性物質のためのコロイド状ナノスケールキャリア及びその製造方法
EP11794970.1A EP2583671A4 (en) 2010-06-15 2011-06-14 COLLOIDAL NANOSCAL CARRIER FOR ACTIVE HYDROPHILIC SUBSTANCES AND METHOD FOR THE PRODUCTION THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1001959-6A BRPI1001959A2 (pt) 2010-06-15 2010-06-15 Nanocarreadores coloidais para ativos hidrofílicos e processo de produção

Publications (1)

Publication Number Publication Date
BRPI1001959A2 true BRPI1001959A2 (pt) 2012-03-06

Family

ID=45347600

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1001959-6A BRPI1001959A2 (pt) 2010-06-15 2010-06-15 Nanocarreadores coloidais para ativos hidrofílicos e processo de produção

Country Status (5)

Country Link
US (1) US20130197100A1 (pt)
EP (1) EP2583671A4 (pt)
JP (1) JP2013530168A (pt)
BR (1) BRPI1001959A2 (pt)
WO (1) WO2011156880A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015123745A1 (pt) * 2014-02-18 2015-08-27 Instituto De Pesquisas Tecnologicas Método de nanoencapsulação de ativos em dupla emulsão inversa e produtos resultantes

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10258698B2 (en) 2013-03-14 2019-04-16 Modernatx, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
AU2014315287A1 (en) 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Chimeric polynucleotides
EP3041938A1 (en) 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Circular polynucleotides
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
US10537860B2 (en) 2014-06-23 2020-01-21 Massachusetts Institute Of Technology Emulsions by condensation
EP3169693B1 (en) 2014-07-16 2022-03-09 ModernaTX, Inc. Chimeric polynucleotides
EP3171895A1 (en) 2014-07-23 2017-05-31 Modernatx, Inc. Modified polynucleotides for the production of intrabodies
MA47016A (fr) 2015-10-22 2018-08-29 Modernatx Inc Vaccins contre les virus respiratoires
LT3394093T (lt) 2015-12-23 2022-04-25 Modernatx, Inc. Ox40 ligandus koduojančių polinukleotidų naudojimo būdai
EP3400023A1 (en) 2016-01-10 2018-11-14 ModernaTX, Inc. Therapeutic mrnas encoding anti ctla-4 antibodies
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
KR102170764B1 (ko) * 2018-11-06 2020-10-27 주식회사 코리아나화장품 나노구조 지질 전달체로 안정화된 유효성분을 함유하는 화장료 조성물
EP4482962A1 (en) 2022-02-24 2025-01-01 IO Biotech ApS Nucleotide delivery of cancer therapy
EP4520345A1 (en) 2023-09-06 2025-03-12 Myneo Nv Product

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
JP2657504B2 (ja) * 1988-01-12 1997-09-24 株式会社資生堂 油中水型乳化組成物
PT100723A (pt) * 1991-07-26 1993-08-31 Smithkline Beecham Corp Microemulsoes de agua em oleo,auto-emulsionantes, estaveis e farmaceuticamente aceitaveis e seu uso
FR2711530B1 (fr) * 1993-10-29 1995-12-01 Oreal Emulsion eau dans huile contenant des polyols et son utilisation en cosmétologie.
US5447354A (en) * 1993-11-10 1995-09-05 Delp; Melvin D. Children's wagon top conversion assembly
JPH1066855A (ja) * 1996-08-26 1998-03-10 Lion Corp W/o型乳化組成物並びに食品用及び医薬品用基剤
JPH1129432A (ja) * 1997-07-04 1999-02-02 Shiseido Co Ltd 油中水型乳化組成物
JPH11188256A (ja) * 1997-12-26 1999-07-13 Nisshin Oil Mills Ltd:The 油性組成物及びその製造方法
JP2004043383A (ja) * 2002-07-12 2004-02-12 Kao Corp 油中水型乳化化粧料
JP4397170B2 (ja) * 2003-03-12 2010-01-13 株式会社Adeka 油中水型可塑性乳化油脂組成物
US20050175651A1 (en) * 2004-01-09 2005-08-11 L'oreal Aqueous dispersion of nanocapsules with an oily core
US7597907B2 (en) 2004-11-05 2009-10-06 Trustees Of The University Of Pennsylvania Antioxidant polymer nanocarriers for use in preventing oxidative injury
JP2006232755A (ja) * 2005-02-25 2006-09-07 Dai Ichi Kogyo Seiyaku Co Ltd 油中水型マイクロエマルション
EP1940355B1 (en) 2005-09-30 2012-12-19 Auburn University Targeted drug delivery nanocarrier comprising a targeting landscape phage protein assembly
JP4840995B2 (ja) * 2007-01-17 2011-12-21 ハイモ株式会社 油中水型分散液の希釈液、その調製方法及びその使用方法
JP2010522196A (ja) * 2007-03-22 2010-07-01 アルカームズ,インコーポレイテッド コアセルベーション工程
EP1972651B1 (en) * 2007-03-23 2012-12-26 Universität Ulm Nanocapsules and process for their production
RU2362544C2 (ru) * 2007-04-09 2009-07-27 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Наноэмульсия с биологически активными веществами
KR100868724B1 (ko) 2007-05-30 2008-11-13 한국생산기술연구원 가역적 온도감응성을 가지는 자기집합성 나노운반체의제조방법
US7927629B2 (en) 2007-10-27 2011-04-19 The Trustees Of The University Of Pennsylvania Method and compositions for polymer nanocarriers containing therapeutic molecules
WO2009123934A2 (en) 2008-03-29 2009-10-08 Emory University Branched multifunctional nanoparticle conjugates and their use
CA2720474A1 (en) 2008-04-04 2009-10-08 Rutgers University Nanocarrier and nanogel compositions
EP2123304A1 (en) 2008-05-23 2009-11-25 Freie Universität Berlin Compounds suited as nanocarriers for active agents and their use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015123745A1 (pt) * 2014-02-18 2015-08-27 Instituto De Pesquisas Tecnologicas Método de nanoencapsulação de ativos em dupla emulsão inversa e produtos resultantes

Also Published As

Publication number Publication date
EP2583671A4 (en) 2014-08-06
US20130197100A1 (en) 2013-08-01
JP2013530168A (ja) 2013-07-25
EP2583671A1 (en) 2013-04-24
WO2011156880A1 (pt) 2011-12-22

Similar Documents

Publication Publication Date Title
BRPI1001959A2 (pt) Nanocarreadores coloidais para ativos hidrofílicos e processo de produção
Marto et al. Pickering emulsions: challenges and opportunities in topical delivery
Sivadasan et al. Cubosomes in drug delivery—a comprehensive review on its structural components, preparation techniques and therapeutic applications
Alkilani et al. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems
Akombaetwa et al. Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications
Sguizzato et al. Lipid-based nanosystems as a tool to overcome skin barrier
Raszewska-Famielec et al. Nanoparticles for topical application in the treatment of skin dysfunctions—an overview of dermo-cosmetic and dermatological products
Khater et al. Design, preparation, and characterization of effective dermal and transdermal lipid nanoparticles: a review
Harman et al. Recent developments in Pickering emulsions for biomedical applications
Syed Azhar et al. Nanostructured lipid carriers-hydrogels system for drug delivery: Nanohybrid technology perspective
Almoshari Novel hydrogels for topical applications: An updated comprehensive review based on source
Gupta et al. Nanocarriers and nanoparticles for skin care and dermatological treatments
Patel et al. Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery
Ridolfi et al. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin
Szulc-Musioł et al. The use of micro-and nanocarriers for resveratrol delivery into and across the skin in different skin diseases—A literature review
Leclercq et al. Pickering emulsions based on cyclodextrins: A smart solution for antifungal azole derivatives topical delivery
Asghar et al. Novel transethosomal gel containing miconazole nitrate; development, characterization, and enhanced antifungal activity
Abolmaali et al. Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications: Pharmaceutical nanoemulsions potential applications
Alhakamy et al. Development, optimization, and evaluation of luliconazole nanoemulgel for the treatment of fungal infection
Lane Nanoparticles and the skin–applications and limitations
El-Zaafarany et al. Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases
San et al. Development of turmeric oil—Loaded chitosan/alginate nanocapsules for cytotoxicity enhancement against breast cancer
Lens Niosomes as vesicular nanocarriers in cosmetics: characterisation, development and efficacy
Abu-Huwaij et al. Exploring the use of niosomes in cosmetics for efficient dermal drug delivery
Altamimi et al. Experimental design based optimization and ex vivo permeation of desmopressin acetate loaded elastic liposomes using rat skin

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements